ATE262346T1 - C-c chemokine die die infektion mit retoviren verhindern - Google Patents
C-c chemokine die die infektion mit retoviren verhindernInfo
- Publication number
- ATE262346T1 ATE262346T1 AT96942818T AT96942818T ATE262346T1 AT E262346 T1 ATE262346 T1 AT E262346T1 AT 96942818 T AT96942818 T AT 96942818T AT 96942818 T AT96942818 T AT 96942818T AT E262346 T1 ATE262346 T1 AT E262346T1
- Authority
- AT
- Austria
- Prior art keywords
- chemokines
- retoviruses
- mip
- prevent infection
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US781795P | 1995-11-30 | 1995-11-30 | |
PCT/US1996/018993 WO1997019696A1 (en) | 1995-11-30 | 1996-11-27 | C-c chemokines that inhibit retrovirus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE262346T1 true ATE262346T1 (de) | 2004-04-15 |
Family
ID=21728273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96942818T ATE262346T1 (de) | 1995-11-30 | 1996-11-27 | C-c chemokine die die infektion mit retoviren verhindern |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0869812B1 (de) |
AT (1) | ATE262346T1 (de) |
AU (1) | AU1141997A (de) |
DE (1) | DE69631971D1 (de) |
WO (1) | WO1997019696A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6548631B1 (en) * | 1997-09-16 | 2003-04-15 | BIOMéRIEUX, INC. | Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
FR2771423A1 (fr) * | 1997-11-21 | 1999-05-28 | Transgene Sa | Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible |
KR19990042713A (ko) * | 1997-11-27 | 1999-06-15 | 허일섭 | 사람에서 분리한 c 6 베타-케모카인 lkn-1의 cdna 및 재조합 lkn-1의 제조방법 |
US6121023A (en) | 1998-01-22 | 2000-09-19 | Akzo Nobel N.V. | Isothermal transcription based assay for the detection and quantification of the chemokine rantes |
CA2326685C (en) * | 1998-04-22 | 2013-08-06 | Chiron Corporation | Enhancing immune responses to genetic immunization by using a chemokine |
US6919318B1 (en) | 1998-04-22 | 2005-07-19 | Chiron Corporation | Enhancing immune responses to genetic immunization by using a chemokine |
EP1100527A2 (de) | 1998-06-01 | 2001-05-23 | University Of Maryland Biotechnology Institute | Antagonistligandrezeptorkomplexen und deren verwendung zur behandlung oder vorbeugung von rezeptor-ermittelten krankheiten |
EP0974357A1 (de) | 1998-07-16 | 2000-01-26 | Schering-Plough | Chemokine als Adjuvantien der Immunantwort |
IT1303736B1 (it) | 1998-11-11 | 2001-02-23 | San Raffaele Centro Fond | Peptidi derivati da rantes con attivita' anti-hiv. |
AU1581301A (en) * | 1999-11-03 | 2001-05-14 | Brigham And Women's Hospital | Human chemokine beta-13 |
US7361329B2 (en) | 2000-04-21 | 2008-04-22 | Chemocentryx, Inc. | Compositions for inducing an immune response |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
EP1723178A4 (de) | 2004-03-12 | 2007-12-12 | Human Genome Sciences Inc | Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565549A (en) * | 1991-11-01 | 1996-10-15 | The Regents Of The University Of California | CD8+ cell antiviral factor |
US5474983A (en) * | 1993-03-15 | 1995-12-12 | The Research Foundation Of State University Of New York | Method of inhibiting pro-inflammatory mediator release from basophils and mast cells |
GB9308060D0 (en) * | 1993-04-19 | 1993-06-02 | Cancer Res Campaign Tech | Stem cell inhibitor |
-
1996
- 1996-11-27 DE DE69631971T patent/DE69631971D1/de not_active Expired - Lifetime
- 1996-11-27 AT AT96942818T patent/ATE262346T1/de not_active IP Right Cessation
- 1996-11-27 EP EP96942818A patent/EP0869812B1/de not_active Expired - Lifetime
- 1996-11-27 AU AU11419/97A patent/AU1141997A/en not_active Abandoned
- 1996-11-27 WO PCT/US1996/018993 patent/WO1997019696A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU1141997A (en) | 1997-06-19 |
EP0869812B1 (de) | 2004-03-24 |
DE69631971D1 (de) | 2004-04-29 |
EP0869812A1 (de) | 1998-10-14 |
WO1997019696A1 (en) | 1997-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE262346T1 (de) | C-c chemokine die die infektion mit retoviren verhindern | |
Pace et al. | Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. | |
PT879056E (pt) | Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados | |
Teunissen et al. | In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL‐10 mRNA and protein | |
MX9203439A (es) | Una citocina mamifera, il-11 | |
DE3784905T2 (de) | Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten. | |
ES2167370T3 (es) | Activacion inmunologica a traves de una terapia intermitente con interleucina-2. | |
ATE306549T1 (de) | C-c ckr-1, ein c-c chemokin rezeptor | |
DE3886986T2 (de) | Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens. | |
FR2643557B1 (fr) | Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv | |
FR2605626B1 (fr) | Nouveaux derives aromatiques bicycliques, leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire | |
DE3650211D1 (de) | Polyätherhomo- oder -copolymer, Monomer dafür und Verfahren zu deren Herstellung. | |
ATE67210T1 (de) | Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten. | |
BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
IT8920186A0 (it) | Catalizzatore di polimerizzazione, procedimento per la sua preparazione e suo impiego nella omo e copolimerizzazione di etilene. | |
IT8522068A0 (it) | Procedimento per la produzione dicloruro di vinile monomero per cracking di dicloroetano e sistema adatto alla conduzione del procedimento. | |
IT1213482B (it) | Processo perfezionato per la polimerizzazione anionica del caprolattame e sua copolimerizzazione con altri lattami. | |
DE69007374D1 (de) | Injektionssystem für die Behandlung von Zellen. | |
MX9700560A (es) | Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales. | |
AU6877587A (en) | Expellants of phytopathogenic microbes | |
Piketty et al. | Failure of antibiotic therapy in Staphylococcus epidermidis infection of implantable venous access devices in patients with AIDS, as documented by molecular typing | |
ES2020176B3 (es) | Composicion de apresto de alcohol polivinilico de actividad elevada en tejidos, poco espumosa. | |
CA2130988A1 (en) | Pharmaceutical Composition for Treatment of Sudden Deafness | |
MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
FI903757A0 (fi) | Anordning foer att loesbart faesta en foersta del i en poeoening pao en andra del. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |